Disclosure of voting rights for Chair of the Board
23 Mayo 2024 - 2:03AM
UK Regulatory
Disclosure of voting rights for Chair of the Board
Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI
Biotech" or the "Company") issue this notification on behalf of
Hans Peter Bøhn, Chair of the Board of Directors.
Hans Peter Bøhn is chair of PCI Biotech’s board
of directors and shall open the annual general meeting of the
Company on 24 May 2024. Mr. Bøhn holds 123,662 shares, representing
0.3 percent of the share capital of PCI Biotech. Mr. Bøhn has
received powers of attorney to represent and vote for 4,288,185
additional shares. In total, Mr. Bøhn will represent and vote for
11.8 percent of the share capital. A major part of the powers of
attorney are without voting instructions. The powers of attorney
are only valid at the annual general meeting on 24 May 2024.
This information is subject to the disclosure
requirements pursuant to section 4 -3, cf. section 5-12 of the
Norwegian Securities Trading Act.
Contact
information:
PCI Biotech
Holding ASA, Ullernchausséen 64, N-0379
Oslo
Ronny Skuggedal, CEO/CFO, rs@pcibiotech.no, Mobile: +47 9400
5757
Pci Biotech Holding Asa (LSE:0JGL)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Pci Biotech Holding Asa (LSE:0JGL)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
